Copyright
©The Author(s) 2017.
World J Gastroenterol. May 21, 2017; 23(19): 3546-3555
Published online May 21, 2017. doi: 10.3748/wjg.v23.i19.3546
Published online May 21, 2017. doi: 10.3748/wjg.v23.i19.3546
Table 3 Comparison of the laryngopharyngeal and gastroesophageal reflux disease typical symptom score between laparoscopic Nissen fundoplication and proton pump inhibitor groups before treatment and at 6-mo and 2-year follow-up
Characteristic/symptom score (No. of LNF/PPI) | Baseline (n = 70) | 6-mo follow-up (n = 61) | 2-yr follow-up (n = 53) | ||||||
LNF | PPI | P value | LNF | PPI | P value | LNF | PPI | P value | |
Regurgitation2 (17/20) | 6.47 ± 0.62 | 6.24 ± 0.56 | 0.385 | 1.41 ± 1.69 | 2.53 ± 1.15 | 0.0221 | 1.12 ± 1.47 | 2.53 ± 1.26 | 0.0051 |
Heartburn2 (19/20) | 6.33 ± 0.68 | 6.30 ± 0.59 | 0.100 | 1.33 ± 1.06 | 2.60 ± 1.69 | 0.0081 | 0.94 ± 1.10 | 3.05 ± 2.20 | 0.0011 |
Cough (15/16) | 7.71 ± 0.82 | 7.67 ± 0.46 | 0.804 | 2.34 ± 2.37 | 4.40 ± 2.10 | 0.0221 | 2.28 ± 2.12 | 5.00 ± 2.28 | 0.0121 |
Mucus (11/9) | 7.09 ± 0.83 | 7.22 ± 0.44 | 0.824 | 2.82 ± 2.24 | 4.77 ± 1.85 | 0.0551 | 3.27 ± 2.18 | 5.29 ± 1.78 | 0.0201 |
Globus (23/14) | 6.10 ± 0.66 | 7.01 ± 0.88 | 0.268 | 2.95 ± 2.75 | 5.43 ± 2.50 | 0.0131 | 2.77 ± 2.87 | 5.28 ± 2.86 | 0.0171 |
Hoarseness (10/7) | 7.30 ± 2.78 | 7.33 ± 2.55 | 0.954 | 3.80 ± 2.69 | 5.00 ± 2.65 | 0.409 | 3.50 ± 2.76 | 4.33 ± 2.53 | 0.546 |
Throat pain (11/4) | 7.20 ± 1.03 | 7.50 ± 0.58 | 0.552 | 3.70 ± 2.98 | 5.50 ± 2.65 | 0.100 | 3.20 ± 3.46 | 4.25 ± 2.06 | 0.166 |
Throat clearing (6/7) | 7.67 ± 0.52 | 7.14 ± 0.52 | 0.063 | 3.33 ± 2.06 | 6.00 ± 1.53 | 0.0341 | 2.83 ± 2.40 | 6.28 ± 1.51 | 0.0201 |
- Citation: Zhang C, Hu ZW, Yan C, Wu Q, Wu JM, Du X, Liu DG, Luo T, Li F, Wang ZG. Nissen fundoplication vs proton pump inhibitors for laryngopharyngeal reflux based on pH-monitoring and symptom-scale. World J Gastroenterol 2017; 23(19): 3546-3555
- URL: https://www.wjgnet.com/1007-9327/full/v23/i19/3546.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i19.3546